Publicaciones en las que colabora con Gonzalo Hernández Vallejo (13)

2023

  1. Salivary biomarkers in burning mouth syndrome: A systematic review and meta-analysis

    Oral Diseases, Vol. 29, Núm. 7, pp. 2600-2613

2022

  1. Salivary LDH in oral cancer and potentially malignant disorders: A systematic review and meta-analysis

    Oral Diseases, Vol. 28, Núm. 1, pp. 44-56

2020

  1. Efficacy of Low-Level Laser Therapy for the Therapeutic Management of Neuropathic Orofacial Pain: A Systematic Review

    Journal of oral & facial pain and headache, Vol. 34, Núm. 1

  2. Oral lesions in patients with primary Sjögren’s syndrome. A case-control cross-sectional study

    Medicina oral, patología oral y cirugía bucal. Ed. inglesa, Vol. 25, Núm. 1, pp. 17

  3. Xerostomia and aalivary flow in patients taking antihypertensive drugs

    International Journal of Environmental Research and Public Health, Vol. 17, Núm. 7

2019

  1. Effects of Xerostom ® products on xerostomia in primary Sjögren’s syndrome: A randomized clinical trial

    Oral Diseases, Vol. 25, Núm. 3, pp. 772-780

  2. Osteonecrosis of the jaws produced by sunitinib: a systematic review

    Medicina oral, patología oral y cirugía bucal. Ed. inglesa, Vol. 24, Núm. 3, pp. 2

2018

  1. Oral lesions in Sjögren’s syndrome: a systematic review

    Medicina oral, patología oral y cirugía bucal. Ed. inglesa, Vol. 23, Núm. 4, pp. 4

2017

  1. Risk factors associated with xerostomia in haemodialysis patients

    Medicina oral, patología oral y cirugía bucal. Ed. inglesa, Vol. 22, Núm. 2, pp. 7

2016

  1. Dabigatran: a new oral anticoagulant. Guidelines to follow in oral surgery procedures. A systematic review of the literature

    Medicina oral, patología oral y cirugía bucal. Ed. inglesa, Vol. 21, Núm. 6, pp. 13

  2. Prevalence of Oral Mucosal Disorders in Diabetes Mellitus Patients Compared with a Control Group

    Journal of Diabetes Research, Vol. 2016

  3. Xerostomia, Hyposalivation, and Salivary Flow in Diabetes Patients

    Journal of Diabetes Research, Vol. 2016

2015

  1. New non-bisphosphonate drugs that produce osteonecrosis of the jaws

    Oral Health and Preventive Dentistry, Vol. 13, Núm. 5, pp. 385-393